Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Alligent Biopharm Consulting

Alligent Biopharm Consulting
2010 FOUNDED
M&A STATUS
21-30 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of medical affair agency services. The company develops and delivers integrated aligned medical communication services to the biopharma industry. It offers clinical trial design, data explorations, supported trial management, publication strategy, TL strategy, slide development and training and specializes in KOL strategy, medical content development and strategic meetings.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Consulting Services (B2B)
Other Industries
Other Healthcare Services
Other Healthcare
Parent Company
Primary Office
  • 331 Elm Street
  • Long Hill, NJ 07980
  • United States

+1 (908) 000-0000

Alligent Biopharm Consulting Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Alligent Biopharm Consulting‘s full profile, request access.

Request full access to PitchBook

Alligent Biopharm Consulting Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Envision Pharma Group Private Equity-Backed Horsham, United Kingdom 000 000000000000
00000000 000000000 Formerly PE-Backed Burlington, MA 0000 000.00 000000&0
0000000000 Private Equity-Backed Princeton, NJ 0000 000.00 000000000000 000.00
00000 Formerly PE-Backed Durham, NC 00000 00.000 000000 - 000 00.000
000000000000 Formerly VC-backed New York, NY 000 00.000 000000&0 00.000
To view this company’s complete list of competitors, request access »

Alligent Biopharm Consulting Executive Team (2)

Name Title Board
Seat
Contact
Info
David Thompson Partner & Managing Director
Joseph Kohles Ph.D Partner & Managing Director